Inhaled colistin in patients with bronchiectasis and chronic Pseudomonas aeruginosa infection.
about
Interventions for bronchiectasis: an overview of Cochrane systematic reviewsDevelopment of Liposomal Ciprofloxacin to Treat Lung InfectionsPrimary ciliary dyskinesia.Bronchiectasis in the Last Five Years: New DevelopmentsInhaled Antibiotics for Gram-Negative Respiratory InfectionsThe EMBARC European Bronchiectasis Registry: protocol for an international observational studyBronchiectasis and Aspergillus: How are they linked?Preventing microbial biofilms on catheter tubes using ultrasonic guided waves.What's new in the management of adult bronchiectasis?Inhaled Antibiotic Therapy in Chronic Respiratory Diseases.Treatment adherence and health outcomes in patients with bronchiectasis.Characterization of lung function impairment in adults with bronchiectasis.Evidence of inhaled tobramycin in non-cystic fibrosis bronchiectasis.Mucin Binding Reduces Colistin Antimicrobial Activity.Longitudinal assessment of sputum microbiome by sequencing of the 16S rRNA gene in non-cystic fibrosis bronchiectasis patients.Genetics, diagnosis, and future treatment strategies for primary ciliary dyskinesia.Multidimensional severity assessment in bronchiectasis: an analysis of seven European cohorts.Predicting high risk of exacerbations in bronchiectasis: the E-FACED score.Antimicrobial treatment of non-cystic fibrosis bronchiectasis.Developing drug therapies in bronchiectasis.Opportunities in respiratory drug delivery.Challenges in the development of new therapies for bronchiectasis.Inhaled antibiotics in the treatment of non-cystic fibrosis bronchiectasis: clinical and drug delivery perspectives.Pediatric bronchiectasis: No longer an orphan disease.Long-term antibiotic treatment for non-cystic fibrosis bronchiectasis in adults: evidence, current practice and future use.Pseudomonas aeruginosa adaptation and diversification in the non-cystic fibrosis bronchiectasis lung.Antibiotic therapy for stable non-CF bronchiectasis in adults - A systematic review.Diagnosis and management of bronchiectasis.Inhaled or nebulised ciprofloxacin for the maintenance treatment of bronchiectasis.Improvement in Quality of Life after Therapy for Mycobacterium abscessus Group Lung Infection. A Prospective Cohort Study.Update in Bronchiectasis 2014.[Colistin inhalation helps against Pseudomonas aeruginosa,].The European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC): experiences from a successful ERS Clinical Research Collaboration.Quality of Life Questionnaire-Bronchiectasis: final psychometric analyses and determination of minimal important difference scores.Nitrite modulates bacterial antibiotic susceptibility and biofilm formation in association with airway epithelial cellsAnnual direct medical costs of bronchiectasis treatment: Impact of severity, exacerbations, chronic bronchial colonization and chronic obstructive pulmonary disease coexistence.The Rationale and Evidence for Use of Inhaled Antibiotics to Control Pseudomonas aeruginosa Infection in Non-cystic Fibrosis Bronchiectasis.Efficacy and safety of long-term inhaled antibiotic for patients with noncystic fibrosis bronchiectasis: a meta-analysis.Reclaiming the name 'bronchiectasis'.The pharmacological treatment of bronchiectasis.
P2860
Q24186645-5F23A01C-D66C-4BAA-AC4A-C715C833EF73Q26764772-AFA47631-713E-46CA-8CAE-EC9CE39F84C4Q27333212-183DDAEE-5AED-49CA-A395-757DFA082805Q28075732-69F81E33-EED3-4B47-B678-88BB1BC64E5DQ28386160-B11FCBCA-C85B-43E5-84A4-98FE4A2A30B5Q28596688-C8A7ACAE-3120-48A9-85EA-D9677DFC9F4DQ30243947-4E7839B6-579D-4A0B-A25D-19BF89CF94BCQ30356435-EA183A90-16F8-42C5-AE9F-EEC939CE94E5Q33589288-BCFEB842-70C2-44D1-80DE-2D5D0030ACB5Q33755342-BDEBCD85-43F6-48F9-99AF-BE40F023185DQ33877099-F36CFEA2-A8B1-4F63-8202-606B8F7DB680Q34535955-8FA8E3D8-364A-497A-8D79-02C4C59158BCQ35426622-9A6949D7-8B92-4F9A-8830-AE773066A323Q36076096-53653544-88B1-4D76-BC4A-27AEC1589E4BQ36272824-72FD6798-2B3B-4BB8-9B05-3A5026ED8CE0Q36692961-434009A8-56CD-499F-B4F0-653F5CBDAA1EQ37471610-F9BAA51E-FEF3-4119-BECB-D2EBE6A2C40EQ37613743-E21893B4-037C-4078-B857-0D352DD01B79Q38243206-5D9A589F-47CA-422D-B04B-EB10093BC4DAQ38259329-9F00E143-AB0A-48B9-B05F-393BADE7F2B9Q38297120-08DE2AD2-A009-46B0-A6A0-63DE27CD3B60Q38387657-6215B771-B4A3-4991-9E6D-CD6C620CAC36Q38569772-C74C0723-22B5-4A15-A156-1C479CFAE96CQ38721361-F4BD4FED-2641-4EB2-B401-D4F95FD777A9Q38797806-71D66228-5E1C-46CA-A20C-0F21550D153FQ38818065-3C22F83E-91B2-461F-B6FB-50DFDB8D9442Q38923436-1C1B14F9-DECB-4BAD-83C1-1BD134CF0F01Q39384458-5030BD64-6E7C-4679-8B4C-5BB94A03C5C4Q40106308-14033BD3-203B-4580-8919-A698AA6E4EE9Q40352533-CBF8885B-0FA2-4E83-9169-F5C3ECDD2AF3Q41122996-787B823D-3C54-4564-8083-BDBB6FF66D8CQ41579686-C1F41C43-1A77-4E17-9ED5-AF1C773337F9Q41615902-7FD4558C-A561-44C6-A0BB-0BA171F79787Q41697766-15CDF297-CE13-4312-A1C5-33FA0D8831E6Q41736354-652DFE6E-7542-4D84-B158-42E7C9629867Q47113028-B211790C-C18A-44DB-BDC0-F9B6920ECA9AQ47730320-10A347FB-A988-40A7-8C1E-D75AD8B5B7BDQ51428053-2F2E8667-FFAC-4294-9EA2-4BA468FB5FDBQ51648266-9FB556E9-2BB3-4F3C-9833-B497D828565EQ51751531-96805B90-A54F-4681-B5AC-677A4ED49F25
P2860
Inhaled colistin in patients with bronchiectasis and chronic Pseudomonas aeruginosa infection.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Inhaled colistin in patients w ...... udomonas aeruginosa infection.
@ast
Inhaled colistin in patients w ...... udomonas aeruginosa infection.
@en
type
label
Inhaled colistin in patients w ...... udomonas aeruginosa infection.
@ast
Inhaled colistin in patients w ...... udomonas aeruginosa infection.
@en
prefLabel
Inhaled colistin in patients w ...... udomonas aeruginosa infection.
@ast
Inhaled colistin in patients w ...... udomonas aeruginosa infection.
@en
P2093
P2860
P1476
Inhaled colistin in patients w ...... udomonas aeruginosa infection.
@en
P2093
Charles S Haworth
Diana Bilton
Juliet E Foweraker
Peter Wilkinson
Robert F Kenyon
P2860
P304
P356
10.1164/RCCM.201312-2208OC
P407
P577
2014-04-01T00:00:00Z